SMART: Use of a Mobile-based App for SCD Patients
Study Details
Study Description
Brief Summary
The study will seek to enroll 100 sickle cell or thalassemia patients who are age 12 or older who have access to a smartphone or tablet with Internet access daily.
The study will evaluate patient-reported comfort level with using a mobile device to record their pain levels, as well as adherence to recording these levels daily.
The study will track patients' assessment of their pain, actions taken, and outcomes related to pain management and provider involvement.
This study will attempt to collect information about differences in the use of two traditional pain assessment modes (verbal scale and paper) versus the use of a pain assessment tool on a mobile device in the form of a smartphone, tablet, or iPad with an Android or iOS operating system.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Detailed Description
The study will evaluate patient-reported comfort level with using a mobile device to record their pain levels, as well as adherence to recording these levels daily. The study will track patients' assessment of their pain, actions taken, and outcomes related to pain management and provider involvement. This study will attempt to collect information about differences in the use of two traditional pain assessment modes (verbal scale and paper) versus the use of a pain assessment tool on a mobile device in the form of a smartphone, tablet, or iPad with an Android or iOS operating system. The study will seek to enroll 100 sickle cell or thalassemia patients who are age 12 or older who have access to a smartphone or tablet with Internet access daily. Patients enrolled in this study will be ask to use a mobile device such as a smartphone or a tablet with Android or iOS operating system to record daily pain level and related information once daily or more frequently for a period of forty-two days. A 1:1 randomization assignment will be made to have patients receive automated "canned" provider feedback or not.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Automated response Canned responses are provided at the end of daily entries |
|
| No automated feedback Canned responses are not provided at the end of daily entries |
Outcome Measures
Primary Outcome Measures
- Usability [42 days]
Patients are able to use a mobile device to record daily symptoms, including pain, and interventions, including medication administration.
Eligibility Criteria
Criteria
Inclusion Criteria:
- SCD, thalassemia, or history of experiencing pain
Exclusion Criteria:
- none
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Duke University Medical Center | Durham | North Carolina | United States | 27710 |
Sponsors and Collaborators
- Duke University
Investigators
- Principal Investigator: Jude Jonassaint, RN, Duke University
- Principal Investigator: Laura De Castro, MD, Duke University
- Principal Investigator: Nirmish Shah, MD, Duke University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Pro00037857